Patient and provider preferences for long-acting TB preventive therapy
BACKGROUND: Tuberculosis preventive therapy (TPT) is critical for TB elimination but is underutilised. Long-acting (LA) TPT can potentially improve linkage to care, treatment adherence and outcomes. METHODS: We conducted a cross-sectional in-person survey in two high TB burden countries to evaluate...
Saved in:
| Main Authors: | M. Vermeulen, K.K. Scarsi, R. Furl, H. Sayles, M.J. Anderson, S. Valawalkar, A. Kadam, S.R. Cox, V. Mave, M. Barthwal, C. Schutz, A. Ward, J. Dountio Ofimboudem, G. Meintjes, S. Rannard, A. Owen, S. Swindells, on behalf of the LONGEVITY consortium |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2025-05-01
|
| Series: | IJTLD Open |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000005/art00006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
World TB Day 2025 Theme “Yes! We Can End TB: Commit, Invest, Deliver” can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and disease
by: Delia Goletti, et al.
Published: (2025-06-01) -
Pulmonary rehabilitation for post-TB lung disease led by TB survivors
by: F.J. Mtei, et al.
Published: (2025-06-01) -
Lung function trajectories in children with pulmonary TB and non-TB lower respiratory tract infections
by: I.J. Courtney, et al.
Published: (2025-08-01) -
World TB Day 2016: Unite to End TB
by: Editorial Article
Published: (2016-02-01) -
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.
by: Jeffrey M Collins, et al.
Published: (2025-01-01)